GLOBAL PREVALENCE OF CHRONIC GLOMERULONEPHRITIS AMONG KIDNEY DISEASES
Keywords:
Keywords: chronic glomerulonephritis, CGN, epidemiology, age-standardized prevalence rate (ASPR), chronic kidney disease.Abstract
Abstract: Chronic glomerulonephritis (CGN) is a progressive immune-mediated inflammation of the renal glomeruli, often resulting in a gradual decline in kidney filtration function. It is classified as a type of chronic kidney disease (CKD) and represents a significant public health challenge worldwide.Recent epidemiological studies indicate that CGN-related CKD affects millions of individuals globally. In 2019, approximately 17.3 million people were estimated to live with CKD caused by CGN. Between 1990 and 2019, the incidence of CGN increased by nearly 81%, a trend associated with population growth, longer life expectancy, and aging populations. During the same period, mortality related to CGN nearly doubled, reflecting the growing burden on healthcare systems.CGN can occur at any age but is most frequently diagnosed among middle-aged and older adults. Some cases are also reported in children and adolescents. Gender differences have been observed, with higher prevalence reported in males compared to females, highlighting the importance of demographic factors in disease screening and prevention strategies.
References
1. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. (2021). KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney International, 100(4 Suppl), S1–S276.
2. Glassock, R. J., & Fervenza, F. C. (2020). Glomerular diseases: New insights and future therapies. The Lancet, 395(10225), 234–246.
3. Levey, A. S., Eckardt, K. U., Dorman, N. M., et al. (2020). Nomenclature for kidney function and disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Kidney International, 97(6), 1117–1129.
4. Ismailov, S. I., Karimov, A. A., & Abdullaeva, N. M. (2022). Clinical features of chronic glomerulonephritis in children in Uzbekistan. Medical Journal of Uzbekistan, 3, 45–49.
5. Saidova, M. A., & Rakhimov, B. R. (2023). Immunogenetic aspects of chronic glomerulonephritis in the Uzbek population. Central Asian Journal of Medical Sciences, 4(2), 78–84.
6. Lv, J., Zhang, H., Wong, M. G., et al. (2021). Effect of intensive blood pressure lowering on the progression of chronic kidney disease. BMJ, 372, n123.
